SILVER SPRING, Md. ̵
An expert panel assembled by the Food and Drug Administration meets for two days from Monday to discuss the latest evidence of risk of disease and complications with the devices used for cosmetic and reconstructive surgery.
THE MODEL HAD BREAST IMPLANTS REMOVED AFTER she says the body is beginning to reject them [TheFDAinterfereswitharecentlyconfirmedlinkbetweentheimplantsandarareformofcancerInadditionmanywomenhavepushedtheagencytoaddressprolonged-butunconfirmed-claimsthatimplantscancontributetootherchronicailments
RISK PLASTIC CITIZENS: BREAST AUGMENTATION, LIPOSION MOST MOST POPULAR PROCEDURES, STUDY FINANCING
The FDA panel will hear from researchers, plastic surgeons, patients, and manufacturers.
CLICK HERE TO GET FOX NEWS APP
For now, the FDA does not propose any new restrictions or warnings.